Jci_page_head_homepage_01 Jci_page_head_homepage_02
Paul A. Crossey, Claire C. Pillai, John P. Miell
Published in Volume 110, Issue 3
J Clin Invest. 2002; 110(3):411–418 doi:10.1172/JCI10077
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

hIGFBP-1 gene expression in maternal decidua and fetal liver. (a) hIGFBP-1 mRNA in decidua of transgenic dams was detected by RT-PCR using a primer pair that specifically amplifies a 372-bp product from hIGFBP-1 cDNA. Lane 1, no template (negative control); lane 2, transgenic mouse liver RNA (positive control); lane 3, wild-type mouse decidua RNA (negative control); lanes 4–6, total RNA extracted decidua of transgenic females sacrificed at the indicated timepoints. M, 100-bp ladder. (b) hIGFBP-1 expression in fetal liver was detected as described in a. Lane 1, no template (negative control); lane 2, transgenic adult mouse liver RNA (positive control); lane 3, wild-type adult mouse liver RNA (negative control); lane 4, wild-type fetal liver RNA; lanes 5 and 6, liver RNA from transgenic fetuses at e14.5 and e17.5, respectively. M, molecular size markers.